Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription elongation regulator 1 pseudogene (ENSG00000270521) is a DNA sequence in the human genome that has high homology to the functional TCERG1 gene but is incapable of producing a functional protein product. Pseudogenes in general are defined as nonfunctional segments of DNA that often arise through gene duplication or retrotransposition, and they may rarely give rise to regulatory RNAs but typically do not play active biological roles[1][3][5][7]. This pseudogene is not considered a receptor, enzyme, transporter, or therapeutic target and does not participate in drug-target interactions or disease processes. Its existence should not be confused with the functional TCERG1 gene, which has established roles in transcription regulation[2][6][8].\n\nClarification: If seeking information on a potential drug target, use *Transcription elongation regulator 1* (TCERG1, ENSG00000113649), not the pseudogene (ENSG00000270521)[2][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription elongation regulator 1 pseudogene.